Novo Nordisk’s Oral Wegovy Nod Lifts Shares, but the Valuation Debate Rages On
Novo Nordisk added another chapter to its recovery story on Wednesday, when European regulators approved the first oral…
Critical Metals Begins Greenland Drilling Campaign With $1.5 Billion Valuation Under Scrutiny
Critical Metals has kicked off a 10,000-metre diamond drilling program at its Tanbreez project in Greenland, one of…
European Lithium’s 40% Valuation Gap Hinges on Greenland Permits, ASX Probe, and A$330M Cash Test
European Lithium shares trade 40% below offer value as unresolved conditions, including a Greenland operating permit and cash…
Pimco, L&G Sued Over €1.2 Billion Brussels Skyscraper Valuation
Pimco and Legal & General Group Plc have been accused of placing “undue pressure” on property valuers in…
Novo Nordisk’s Ozempic Pill Hits Shelves as Q1 Earnings Loom and Valuation Debate Deepens
Novo Nordisk faces a pivotal week with Ozempic oral launch, expected Q1 earnings decline, and a 36% stock…
Q1 Earnings Loom as Valuation Debate Intensifies
Novo Nordisk faces pivotal Q1 earnings amid a 36% YTD stock drop, competitive pressure from Eli Lilly, and…
Generics, Price Wars, and a Steep Valuation Gap
Novo Nordisk faces a turbulent period with a 20% stock drop, Eli Lilly’s US market dominance, and Canada’s…
European Lithium’s Valuation Gap Narrows as Greenland Project Advances
European Lithium’s 12% surge follows Greenland project approval, revealing a valuation gap where its cash and Critical Metals…
The Valuation Conundrum Facing Ørsted Investors
Ørsted’s stock price is caught between bullish DCF models and conservative risk assessments, fueled by US project progress…